Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-04-19

FDA Approved: LAMIVUDINE — Original Application (Strides Pharma Science Limited)

View source ↗

Summary

FDA approved Strides Pharma Science Limited's original ANDA for lamivudine, a generic antiviral used to treat HIV-1 infection and chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamivudine (generic) (Lamivudine)

Snippet

ORIG AP for LAMIVUDINE (LAMIVUDINE)